| UniProt ID | ERR1_HUMAN | |
|---|---|---|
| UniProt AC | P11474 | |
| Protein Name | Steroid hormone receptor ERR1 | |
| Gene Name | ESRRA | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 423 | |
| Subcellular Localization | Nucleus . Cytoplasm . Co-localizes to the cytoplasm only in presence of MAPK15. | |
| Protein Description | Binds to an ERR-alpha response element (ERRE) containing a single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium-chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and may act as an important regulator of MCAD promoter. Binds to the C1 region of the lactoferrin gene promoter. Requires dimerization and the coactivator, PGC-1A, for full activity. The ERRalpha/PGC1alpha complex is a regulator of energy metabolism. Induces the expression of PERM1 in the skeletal muscle.. | |
| Protein Sequence | MSSQVVGIEPLYIKAEPASPDSPKGSSETETEPPVALAPGPAPTRCLPGHKEEEDGEGAGPGEQGGGKLVLSSLPKRLCLVCGDVASGYHYGVASCEACKAFFKRTIQGSIEYSCPASNECEITKRRRKACQACRFTKCLRVGMLKEGVRLDRVRGGRQKYKRRPEVDPLPFPGPFPAGPLAVAGGPRKTAAPVNALVSHLLVVEPEKLYAMPDPAGPDGHLPAVATLCDLFDREIVVTISWAKSIPGFSSLSLSDQMSVLQSVWMEVLVLGVAQRSLPLQDELAFAEDLVLDEEGARAAGLGELGAALLQLVRRLQALRLEREEYVLLKALALANSDSVHIEDAEAVEQLREALHEALLEYEAGRAGPGGGAERRRAGRLLLTLPLLRQTAGKVLAHFYGVKLEGKVPMHKLFLEMLEAMMD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSSQVVGIE ------CCCCCCCEE | 29.49 | 23663014 | |
| 3 | Phosphorylation | -----MSSQVVGIEP -----CCCCCCCEEE | 26.20 | 23663014 | |
| 14 | Sumoylation | GIEPLYIKAEPASPD CEEEEEEEEEECCCC | 32.89 | - | |
| 14 | Sumoylation | GIEPLYIKAEPASPD CEEEEEEEEEECCCC | 32.89 | 17676930 | |
| 19 | Phosphorylation | YIKAEPASPDSPKGS EEEEEECCCCCCCCC | 39.70 | 29255136 | |
| 22 | Phosphorylation | AEPASPDSPKGSSET EEECCCCCCCCCCCC | 31.71 | 29255136 | |
| 26 | Phosphorylation | SPDSPKGSSETETEP CCCCCCCCCCCCCCC | 31.00 | 30278072 | |
| 27 | Phosphorylation | PDSPKGSSETETEPP CCCCCCCCCCCCCCC | 58.15 | 30278072 | |
| 29 | Phosphorylation | SPKGSSETETEPPVA CCCCCCCCCCCCCCE | 50.59 | 30278072 | |
| 31 | Phosphorylation | KGSSETETEPPVALA CCCCCCCCCCCCEEC | 62.30 | 30278072 | |
| 44 | Phosphorylation | LAPGPAPTRCLPGHK ECCCCCCCCCCCCCC | 35.80 | 20068231 | |
| 51 | Acetylation | TRCLPGHKEEEDGEG CCCCCCCCCCCCCCC | 73.13 | 26051181 | |
| 68 | Acetylation | PGEQGGGKLVLSSLP CCCCCCCEEEECCCC | 38.40 | 26051181 | |
| 73 | Phosphorylation | GGKLVLSSLPKRLCL CCEEEECCCCCEEEE | 44.52 | 28555341 | |
| 76 | Ubiquitination | LVLSSLPKRLCLVCG EEECCCCCEEEEEEC | 64.39 | - | |
| 95 | Phosphorylation | GYHYGVASCEACKAF CCHHCHHCHHHHHHH | 15.30 | 24275569 | |
| 116 | Phosphorylation | GSIEYSCPASNECEI CCEEEECCCCCCCCH | 32.55 | 17676930 | |
| 119 | Phosphorylation | EYSCPASNECEITKR EEECCCCCCCCHHHH | 61.11 | 17676930 | |
| 124 | Phosphorylation | ASNECEITKRRRKAC CCCCCCHHHHHHHHH | 9.01 | 15302935 | |
| 129 | Acetylation | EITKRRRKACQACRF CHHHHHHHHHHHCHH | 52.26 | 20484414 | |
| 137 | Phosphorylation | ACQACRFTKCLRVGM HHHHCHHHHHHCCCC | 11.07 | 26074081 | |
| 138 | Acetylation | CQACRFTKCLRVGML HHHCHHHHHHCCCCC | 28.67 | 20484414 | |
| 146 | Ubiquitination | CLRVGMLKEGVRLDR HHCCCCCCCCCCHHH | 43.46 | - | |
| 160 | Acetylation | RVRGGRQKYKRRPEV HCCCCHHHCCCCCCC | 51.91 | 20484414 | |
| 162 | Acetylation | RGGRQKYKRRPEVDP CCCHHHCCCCCCCCC | 49.30 | 20484414 | |
| 189 | Sumoylation | AVAGGPRKTAAPVNA EECCCCCCCCHHHHH | 45.72 | 28112733 | |
| 189 | Sumoylation | AVAGGPRKTAAPVNA EECCCCCCCCHHHHH | 45.72 | - | |
| 190 (in isoform 2) | Phosphorylation | - | 29.36 | 20068231 | |
| 362 | Phosphorylation | LHEALLEYEAGRAGP HHHHHHHHHHHCCCC | 15.85 | - | |
| 403 | Sumoylation | LAHFYGVKLEGKVPM HHHHHCCCCCCCCCH | 36.14 | 17676930 | |
| 403 | Ubiquitination | LAHFYGVKLEGKVPM HHHHHCCCCCCCCCH | 36.14 | - | |
| 403 | Sumoylation | LAHFYGVKLEGKVPM HHHHHCCCCCCCCCH | 36.14 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ERR1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference |
|---|---|---|---|---|
| 14 | K | Phosphorylation |
| 17676930 |
| 14 | K | Phosphorylation |
| 17676930 |
| 14 | K | Sumoylation |
| 17676930 |
| 19 | S | Phosphorylation |
| 17676930 |
| 19 | S | Phosphorylation |
| 17676930 |
| 19 | S | Sumoylation |
| 17676930 |
| 129 | K | Acetylation |
| 20484414 |
| 138 | K | Acetylation |
| 20484414 |
| 160 | K | Acetylation |
| 20484414 |
| 162 | K | Acetylation |
| 20484414 |
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ERR1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ERR3_HUMAN | ESRRG | physical | 17157980 | |
| NRIP1_HUMAN | NRIP1 | physical | 16439465 | |
| PRGC1_HUMAN | PPARGC1A | physical | 15337744 | |
| ERR3_HUMAN | ESRRG | physical | 17488637 | |
| KAT2B_HUMAN | KAT2B | physical | 20484414 | |
| SIR1_HUMAN | SIRT1 | physical | 20484414 | |
| HDAC8_HUMAN | HDAC8 | physical | 20484414 | |
| PRKN_HUMAN | PARK2 | physical | 21177257 | |
| ERR3_HUMAN | ESRRG | physical | 15604093 | |
| DUT_HUMAN | DUT | physical | 15604093 | |
| PROX1_HUMAN | PROX1 | physical | 15604093 | |
| TNNI2_HUMAN | TNNI2 | physical | 15604093 | |
| NR0B2_HUMAN | NR0B2 | physical | 15604093 | |
| MACF1_HUMAN | MACF1 | physical | 15604093 | |
| ERR3_HUMAN | ESRRG | physical | 18673300 | |
| WDR36_HUMAN | WDR36 | physical | 22939629 | |
| ZN606_HUMAN | ZNF606 | physical | 22939629 | |
| IPO13_HUMAN | IPO13 | physical | 22939629 | |
| C2CD5_HUMAN | C2CD5 | physical | 22939629 | |
| ESR1_HUMAN | ESR1 | physical | 9395481 | |
| FUS_HUMAN | FUS | physical | 21988832 | |
| MP2K5_HUMAN | MAP2K5 | physical | 21988832 | |
| NXF1_HUMAN | NXF1 | physical | 21988832 | |
| PIAS4_HUMAN | PIAS4 | physical | 21988832 | |
| NCOA1_HUMAN | NCOA1 | physical | 23975195 | |
| NCOA1_HUMAN | NCOA1 | physical | 15604093 | |
| PRS8_HUMAN | PSMC5 | physical | 15604093 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-22 AND SER-26,AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-22, AND MASSSPECTROMETRY. | |
| "Phosphorylation-dependent sumoylation regulates estrogen-relatedreceptor-alpha and -gamma transcriptional activity through a synergycontrol motif."; Tremblay A.M., Wilson B.J., Yang X.-J., Giguere V.; Mol. Endocrinol. 22:570-584(2008). Cited for: SUMOYLATION AT LYS-14 AND LYS-403, PHOSPHORYLATION AT SER-19 ANDSER-22, INTERACTION WITH PIAS4, FUNCTION, SUBCELLULAR LOCATION, ANDMUTAGENESIS OF LYS-14; SER-19; SER-22 AND LYS-403. | |
| "Phosphorylation-dependent sumoylation of estrogen-related receptoralpha1."; Vu E.H., Kraus R.J., Mertz J.E.; Biochemistry 46:9795-9804(2007). Cited for: SUMOYLATION AT LYS-14 AND LYS-403, PHOSPHORYLATION AT SER-19 ANDSER-22, FUNCTION, AND MUTAGENESIS OF LYS-14; SER-19; SER-22; LYS-403;LEU-413 AND LEU-418. | |
| "Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22 AND SER-27, AND MASSSPECTROMETRY. | |
| Sumoylation | |
| Reference | PubMed |
| "Phosphorylation-dependent sumoylation regulates estrogen-relatedreceptor-alpha and -gamma transcriptional activity through a synergycontrol motif."; Tremblay A.M., Wilson B.J., Yang X.-J., Giguere V.; Mol. Endocrinol. 22:570-584(2008). Cited for: SUMOYLATION AT LYS-14 AND LYS-403, PHOSPHORYLATION AT SER-19 ANDSER-22, INTERACTION WITH PIAS4, FUNCTION, SUBCELLULAR LOCATION, ANDMUTAGENESIS OF LYS-14; SER-19; SER-22 AND LYS-403. | |
| "Phosphorylation-dependent sumoylation of estrogen-related receptoralpha1."; Vu E.H., Kraus R.J., Mertz J.E.; Biochemistry 46:9795-9804(2007). Cited for: SUMOYLATION AT LYS-14 AND LYS-403, PHOSPHORYLATION AT SER-19 ANDSER-22, FUNCTION, AND MUTAGENESIS OF LYS-14; SER-19; SER-22; LYS-403;LEU-413 AND LEU-418. | |